Reply to "Plasma imatinib trough levels for predicting efficacy and toxicity in patients with chronic myeloid leukemia in chronic phase: Still a matter of debate!"
Fang ChengFang ZengQiang LiZheng CuiYilin ChenWei-Ming LiYu ZhangPublished in: Cancer (2022)